PMID: 2121540Oct 29, 1990Paper

Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence

FEBS Letters
M O'HareJ M Lord

Abstract

Chimeric proteins composed of ricin toxin A chain (RTA) and staphylococcal protein A (PA) have been produced in E. coli. Constructs consisting of N-terminal RTA and C-terminal PA (RTA-PA) or N-terminal PA and C-terminal (PA-RTA) were capable of binding to immunoglobulin G (via PA) and of specifically depurinating 28 S ribosomal RNA (via RTA). However, neither fusion protein was cytotoxic to antigen-bearing target cells in the presence of an appropriate monoclonal antibody presumably because the RTA could not be released from the PA within the cytosol where the ribosomal substrate of RTA is located. The overcome this, a short amino acid sequence from diphtheria toxin was engineered between the RTA and PA to produce a disulfide-linked loop containing a trypsin sensitive cleavage site. Cleavage of this fusion protein with trypsin converted the RTA-DT-PA to the two chain form consisting of RTA linked by a disulfide bond to PA. The cleaved fusion protein was highly toxic to Daudi cells coated with anti-immunoglobulin antibody suggesting that the RTA could be released from the PA by reduction within the cytosol.

References

Feb 27, 1989·FEBS Letters·K HussainJ M Lord
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J R MurphyS Nagle
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·V K ChaudharyI Pastan
Nov 20, 1987·Science·E S VitettaJ W Uhr
May 25, 1987·FEBS Letters·M O'HareJ M Lord
Apr 15, 1985·European Journal of Biochemistry·F I LambJ M Lord
Sep 1, 1971·Nature: New Biology·T UchidaA M Pappenheimer
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L GreenfieldD A Kaplan

❮ Previous
Next ❯

Citations

Sep 1, 1994·Pharmacology & Therapeutics·V Ghetie, E Vitetta
May 27, 1994·Biochimica Et Biophysica Acta·U Brinkmann, I Pastan
Oct 1, 1994·Current Opinion in Immunology·M A Ghetie, E S Vitetta
Aug 1, 1992·Current Opinion in Biotechnology·L M Roberts, J M Lord
Oct 1, 1996·Molecular Medicine Today·U Brinkmann
Dec 24, 1997·Leukemia Research·R J Kreitman
Sep 6, 2002·Vaccine·Joan E SmallshawEllen S Vitetta
Nov 1, 1995·European Journal of Biochemistry·J B FerriniB Beaumelle
Jan 1, 1996·Annual Review of Immunology·G R ThrushE S Vitetta
Nov 10, 2011·Toxins·Maddalena de VirgilioMaria Serena Fabbrini
Oct 18, 2000·Biochemical and Biophysical Research Communications·A SchmidtH Zinke
Oct 4, 2005·Biochemical and Biophysical Research Communications·Christopher BachranMark Sutherland
Nov 1, 1994·Bioconjugate Chemistry·L B AfrinA E Frankel
Mar 6, 2007·Journal of Immunological Methods·Yariv MazorItai Benhar
Feb 26, 2000·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A E FrankelE A Sausville
Aug 29, 1997·The Journal of Biological Chemistry·B BeaumelleL M Roberts
Jun 23, 1995·The Journal of Biological Chemistry·M BetterD M Fishwild
Apr 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fang WangAn-Gang Yang
Feb 1, 1994·Infection and Immunity·V M Gordon, S H Leppla
Nov 22, 1991·Science·I Pastan, D FitzGerald

❮ Previous
Next ❯

Related Concepts

Related Feeds